Insiders / Stengone Carmine N.

Stengone Carmine N.

CIK 1861519personinsider

Companies

2

First seen

Jan 30, 2026

Last activity

Jun 12, 2026

Companies

Company	Role	Shares held	Peak held	Trades	Latest
Contineum Therapeutics, Inc. · CTNM	CEO	14,954	445,000	10	—
Kiora Pharmaceuticals, Inc. · KPRX	Director	—	25,000	1	—

All securities held

3 positions · latest reported per filing

Company	Security	Shares	As of
Contineum Therapeutics, Inc.	Class A Common Stock	14,954	Feb 25, 2026
Contineum Therapeutics, Inc.	Stock Option (right to buy)Derivative	120,917	Feb 25, 2026
Kiora Pharmaceuticals, Inc.	Stock Option (right to buy)Derivative	25,000	Jun 10, 2026

Activity

InsidersInstitutions

This person's insider trades (Form 4), across every company.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Feb 24, 2026	Sell	CTNM Contineum Therapeutics, Inc. Class A Common Stock	$70.5K	-4K -22.73%	14,954 0.04% of shares	low
Feb 25, 2026	Sell	CTNM Contineum Therapeutics, Inc. Class A Common Stock	$43.2K	-3K -15.29%	14,954 0.04% of shares	low
Feb 11, 2026	Sell	CTNM Contineum Therapeutics, Inc. Class A Common Stock	$6.4K	-400 -2.61%	14,954 0.04% of shares	low
Feb 24, 2026	Exercise	CTNM Contineum Therapeutics, Inc. Class A Common Stock	$5.5K	+4K +29.42%	19,354 0.05% of shares	low
Feb 25, 2026	Exercise	CTNM Contineum Therapeutics, Inc. Class A Common Stock	$3.4K	+3K +18.06%	17,654 0.05% of shares	low
Feb 11, 2026	Exercise	CTNM Contineum Therapeutics, Inc. Class A Common Stock	$504	+400 +2.67%	15,354 0.04% of shares	low
Jun 10, 2026	Grant	KPRX Kiora Pharmaceuticals, Inc. Stock Option (right to buy)	—	+25K	25,000 0.57% of shares	low
Feb 25, 2026	Exercise	CTNM Contineum Therapeutics, Inc. Stock Option (right to buy)	—	-3K -2.18%	120,917 0.32% of shares	low
Feb 24, 2026	Exercise	CTNM Contineum Therapeutics, Inc. Stock Option (right to buy)	—	-4K -3.44%	123,617 0.33% of shares	low
Feb 11, 2026	Exercise	CTNM Contineum Therapeutics, Inc. Stock Option (right to buy)	—	-400 -0.31%	128,017 0.34% of shares	low